Answers are grounded in this paper and cite their sources.
Oral ribavirin should be considered for the treatment of NIRVI in immunocompromised adults (malignancy/stem cell transplant or lung transplant) or adults with MERS-CoV.
No takes yet. Share an insight, caveat, or question.
Gross et al. (2015) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: